Patient Alert: Our scheduling system is back online. The appointment reminder system is still down, appointment reminders are not currently being sent.

Trial Protocol ID
USOR 21270_ZN-c3-005 *RIT*

Investigator
Syed Shahid Mahmood, M.D.

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Trial Protocol ID
USOR 21271_ZN-c3-004 | GOG 3065_TITAN

Investigator
Jeanine L Werner, M.D.

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma (ZN-c3-004 | GOG 3065) (TITAN)

Trial Protocol ID
USOR 22272_KRT-232-118 | GOG 3089

Investigator
Vinni Juneja, M.D.

A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects with TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy (KRT-232-118)

Trial Protocol ID
USOR 22093_XB002-101_Jewel-101

Investigator
Yousuf A. Gaffar, M.D.

A DOSE-ESCALATION AND EXPANSION STUDY OF THE SAFETY AND PHARMACOKINETICS OF XB002 AS SINGLE-AGENT AND COMBINATION THERAPY IN SUBJECTS WITH INOPERABLE LOCALLY ADVANCED OR METASTATIC SOLID TUMORS (XB002-101)